indazoles has been researched along with Bowel Diseases, Inflammatory in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, J; Huang, S; Li, QJ; Long, H; Symonds, ALJ; Tang, X; Wan, YY; Wang, Z; Xu, L; Zhou, J; Zhu, B | 1 |
| Aicher, TD; Al-Mossawi, MH; Arancibia-Cárcamo, CV; Barr, K; Bowness, P; Correll, C; de Wit, J; Doig, K; Glick, GD; Gundle, R; Hu, X; Hühn, MH; Kendrick, B; Mcclanahan, T; Miller, JR; Morgan, RW; Murphy, E; Powrie, F; Taylor, P; Zaller, D; Zhang, H | 1 |
| Dannenberg, AJ; Das, KM; Glazier, KD; Golijanin, D; Naraba, H; Scherl, E; Soslow, RA; Subbaramaiah, K; Tanabe, T; Yoshimatsu, K | 1 |
3 other study(ies) available for indazoles and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation.
Topics: Animals; Cell Differentiation; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Female; Hematopoietic Stem Cells; Histone Code; Histones; In Vitro Techniques; Indazoles; Indoles; Inflammatory Bowel Diseases; Methylation; Mice; Myeloid-Derived Suppressor Cells; Pyridones | 2019 |
RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease.
Topics: Arthritis; Gene Expression Regulation; Humans; Indazoles; Inflammatory Bowel Diseases; Interleukin-17; Nuclear Receptor Subfamily 1, Group F, Member 3; T-Lymphocyte Subsets; Th17 Cells | 2016 |
Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor Egr-1.
Topics: Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cells, Cultured; Colon; DNA-Binding Proteins; Dose-Response Relationship, Drug; Early Growth Response Protein 1; Enzyme Activators; Enzyme Inhibitors; Guanylate Cyclase; Humans; Immediate-Early Proteins; Immunoblotting; Immunohistochemistry; Indazoles; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Intramolecular Oxidoreductases; Luciferases; Microsomes; Models, Biological; Nitric Oxide; Oligonucleotides, Antisense; Plasmids; Promoter Regions, Genetic; Prostaglandin-E Synthases; Protein Kinase C; RNA Interference; Signal Transduction; Transcription Factors; Transcription, Genetic; Transfection; Tumor Necrosis Factor-alpha; Type C Phospholipases | 2004 |